“[I]t is likely that lowering drug prices will actually result in better health outcomes. If there is no one who has a major incentive to mislead the public about the safety and effectiveness of a drug, we are more likely to get accurate information about the usefulness of different drugs for treating various conditions.” @DeanBaker13 on a Biden administration proposal to use a provision of the Bayh-Dole Act to limit prices of drugs derived from government-funded research https://cepr.net/bidens-move-on-bayh-dole-important-first-step-in-dealing-with-patent-monopolies-and-high-prices/